Serum Copper In Thalassemic Adolescents: Relations to Bone Mass Abnormalities

MR Bekheirnia; AA Shamshirsaz; M Kamgar; G Erfanzadeh; N Bouzari; SM Tabatabaie; b Larijani

Zahedan Journal of Research in Medical Sciences

The Official Journal of Zahedan University of Medical Sciences

Current Issue All Issues In Press Articles Accepted Manuscripts Search

Journal Information Boards and Committees Indexing and Listing Sources Journal Metrics Open Peer Review (OPR)Publication Ethics and Malpractice Statement Contact Us Support Reviewer and AE Registration Form

APC

Authors Guide Submit Manuscript

Serum Copper In Thalassemic Adolescents: Relations to Bone Mass Abnormalities

Author(s):

MR Bekheirnia^1,*,

AA Shamshirsaz¹,

M Kamgar¹,

G Erfanzadeh¹,

N Bouzari²,

SM Tabatabaie²,

b Larijani¹

1Endocrinology and Metabolism Research Center, Tehran University of Medical Sciences and Health Services, Tehran, Iran.

2Charity foundation for special diseases, Tehran, Iran.

Zahedan Journal of Research in Medical Sciences:Vol. 5, issue 2; e95141

Published online:Jun 26, 2003

Article type:Research Article

Received:Jun 05, 2003

Accepted:Jun 17, 2003

How to Cite:MR BekheirniaAA ShamshirsazM KamgarG ErfanzadehN BouzariSM Tabatabaieb Larijaniet al.Serum Copper In Thalassemic Adolescents: Relations to Bone Mass Abnormalities.Zahedan J Res Med Sci.5(2):e95141.

Abstract

This study aims at determining serum copper profile in β-thalassemic patients
and the possible association with bone mineral density (BMD) abnormalities. In
one hundred thirty one transfusion-dependent β-thalassemic adolescents, serum
levels of copper were measured by Flame-Atomic Absorption Spectrophotometry.
BMD values at lumbar (L1-L4) and femoral neck were determined by dual x-ray
absorptiometry (DXA). Food frequency questionnaire was used to determine
patients' dietary copper and calcium intake. Patients’ history of treatment and
demographic data were obtained. Low serum copper was seen in 67.7% of female
and 75.7% of male patients. Female patients with low therapeutic index (<0.025)
had higher serum copper level (p<0.05). Mean of copper intakes were 0.41±1.08
mg/day in the evaluated patients. Serum copper showed no association with BMD
abnormalities neither in lumbar nor in femoral areas. We need more studies to
explore different causes of low serum copper levels in our patients; however
dietary modification and oral supplementation (under close observation) in these
patients are recommended.

Keywords

Fulltext

The full text of this article is available on the PDF file.

References

1.
The References of this article are available on the PDF file.

comments